期刊首页 优先出版 当期阅读 过刊浏览 作者中心 关于期刊 English

《中国工程科学》 >> 2021年 第23卷 第1期 doi: 10.15302/J-SSCAE-2021.01.022

整合药学发展的战略思考

1. 哈尔滨医科大学药学院,哈尔滨 150081;

2. 心血管药物研究教育部重点实验室,哈尔滨 150081;

3. 哈尔滨医科大学省部共建国家重点实验室培育基地,哈尔滨 150081

资助项目 :中国工程院咨询项目“整合医学战略研究(2035)”(2018-ZD-09) 收稿日期: 2020-11-20 修回日期: 2020-12-22 发布日期: 2021-01-22

下一篇 上一篇

摘要

整合药学是以现代药学为基础、随着人类对复杂性疾病认识的日益深刻而提出来的,涉及新药研发、传统医药创新、 临床药学实践、药学学科建设及人才培养等诸多领域。为推进我国整合药学实践的发展,本文运用文献研究、学术交流、专 家咨询等方法,阐明了整合药学理念及内涵,提出了整合药学的未来发展战略。研究指出,要促进现代药学与传统药学的整 合,应建立健全整合用药临床实践指南、鼓励基于整合思维的创新中药研究、规范整合中西药临床应用;推进基于整合药学 的新药研发,应创新整合药物设计思路、开发适应整合药学的药物评价体系、加快建设整合药物的新药研发体系;推进整合 药学的临床实践,应进一步完善以患者为中心的临床用药指导、实现个体化治疗、丰富整合药学临床实践内容、加强整合药 物合理应用;推进整合药学学科建设,应丰富基于整合药学的药学本科理论和实践课程、加强教育培训及专业间协作。整合 药学是现代药学理论和实践的变革与发展,融合药学各相关学科的理论与实践,是构建促进人类健康、完善医疗体系的新型 药学理论和实践体系。

参考文献

[ 1 ] 樊代明. 整合医学的内涵与外延 [J]. 医学与哲学, 2017, 38(1): 7–13. Fan D M. The connotation and extension of holistic integrative medicine [J]. Medicine and Philosophy, 2017, 38(1): 7–13.
Fan D M. The connotation and extension of holistic integrative medicine [J]. Medicine and Philosophy, 2017, 38(1): 7–13. Chinese. 链接1

[ 2 ] 樊代明. 整合医学再探 [C]//樊代明. 整合医学——理论与实践. 西安: 世界图书出版公司, 2016: 55–66. Fan D M. Re-discussion for holistic integrated medicine [C]// Fan D M. Holistic integrative medicine: Theory & practice. Xi’an: World Publishing Corporation, 2016: 55–66.
Fan D M. Re-discussion for holistic integrated medicine [C]// Fan D M. Holistic integrative medicine: Theory & practice. Xi’an: World Publishing Corporation, 2016: 55–66. Chinese.

[ 3 ] 郭姣, 陈钢, 索蓄斌, 等. 整合药学——药学教育发展新时代 [J]. 药学教育, 2018, 34(3): 1–4. Guo J, Chen G, Suo X B, et al. Holistic integrated pharmacy: A new era of pharmaceutical education [J]. Pharmaceutical Education, 2018, 34(3): 1–4.
Guo J, Chen G, Suo X B, et al. Holistic integrated pharmacy: A new era of pharmaceutical education [J]. Pharmaceutical Education, 2018, 34(3): 1–4. Chinese. 链接1

[ 4 ] 吴以岭. 络病诊治理论及药物开发中的整合医学思维 [C]//樊 代明. 整合医学——理论与实践③. 西安: 世界图书出版公司, 2018: 535–540. Wu Y L. Theory of diagnosis and treatment of collateral disease and holistic integrative medical thinking [C]//Fan D M. Holistic integrative medicine: Theory & practice③. Xi’an: World Publishing Corporation, 2018: 535–540.
Wu Y L. Theory of diagnosis and treatment of collateral disease and holistic integrative medical thinking [C]//Fan D M. Holistic integrative medicine: Theory & practice③. Xi’an: World Publishing Corporation, 2018: 535–540. Chinese.

[ 5 ] 王广基. 整合药学大有可为 [C]//樊代明. 整合医学——理论与 实践③. 西安: 世界图书出版公司, 2018: 529–534. Wang G J. There is much to be done in integrative medicine [C]// Fan D M. Holistic integrative medicine: Theory & practice③. Xi’an: World Publishing Corporation, 2018: 529–534.
Wang G J. There is much to be done in integrative medicine [C]// Fan D M. Holistic integrative medicine: Theory & practice③. Xi’an: World Publishing Corporation, 2018: 529–534. Chinese.

[ 6 ] 李锋. 整合中医药学的发展前途光明 [C]//樊代明. 整合医 学——理论与实践③. 西安: 世界图书出版公司, 2018: 515–517. Li F. The future of integrative traditional Chinese medicine is bright [C]//Fan D M. Holistic integrative medicine: Theory & practice③. Xi’an: World Publishing Corporation, 2018: 515–517.
Li F. The future of integrative traditional Chinese medicine is bright [C]//Fan D M. Holistic integrative medicine: Theory & practice③. Xi’an: World Publishing Corporation, 2018: 515–517. Chinese.

[ 7 ] 吴以岭, 常丽萍. “理论—临床—新药—实验—循证”中医药创 新发展新模式 [C]. 济南: 第十四届国际络病学大会, 2018. Wu Y L, Chang L P. “Theory-clinical-new drug-experimentevidence-based” new model of traditional Chinese medicine [C]. Ji’nan: The 14th International Congress of Collateral Disease, 2018.
Wu Y L, Chang L P. “Theory-clinical-new drug-experiment evidence-based” new model of traditional Chinese medicine [C]. Ji’nan: The 14th International Congress of Collateral Disease, 2018. Chinese.

[ 8 ] Yao D N, Hu H, Harnett J E, et al. Integrating traditional Chinese medicines into professional community pharmacy practice in China: Key stakeholder perspectives [J]. European Journal of Integrative Medicine, 2020, 34: 1–8. 链接1

[ 9 ] Tian X Y, Liu L. Drug discovery enters a new era with multi-target intervention strategy [J]. Chinese Journal of Integrative Medicine, 2012, 18(7): 539–542. 链接1

[10] Gu S, Pei J F. Chinese herbal medicine meets biological networks of complex diseases: a computational perspective [J]. Evidencebased Complementary and Alternative Medicine, 2017, 2017: 1–7. 链接1

[11] Wang Y, Fan X H, Qu H B, et al. Strategies and techniques for multi-component drug design from medicinal herbs and traditional Chinese medicine [J]. Current Topics in Medicinal Chemistry, 2012, 12(12): 1356–1362. 链接1

[12] Chong C R, Sullivan D J. New uses for old drugs [J]. Nature, 2007, 448(7154): 645–646. 链接1

[13] 崔建梅, 尹大力. 药物重新定位策略在新药发现中的应用与进 展 [J]. 中国药学杂志, 2005, 40(20): 1524–1526. Cui J M, Yin D L. Application and progress of drug repositioning in discovering new drugs [J]. Chinese Pharmaceutical Journal, 2005, 40(20): 1524–1526.
Cui J M, Yin D L. Application and progress of drug repositioning in discovering new drugs [J]. Chinese Pharmaceutical Journal, 2005, 40(20): 1524–1526. Chinese. 链接1

[14] Boguski M S, Mandl K D, Sukhatme V P. Drug discovery repurposing with a difference [J]. Science, 2009, 324(5933): 1394–1395. 链接1

[15] 樊代明. 医药互为师 [C]//樊代明. 整合医学——理论与实践. 西 安: 世界图书出版公司, 2016: 138–145. Fan D M. Medicine and drug are teachers to each other [C]//Fan D M. Holistic integrative medicine: Theory & practice. Xi’an: World Publishing Corporation, 2016: 138–145.
Fan D M. Medicine and drug are teachers to each other [C]//Fan D M. Holistic integrative medicine: Theory & practice. Xi’an: World Publishing Corporation, 2016: 138–145. Chinese.

[16] Li J, Zheng S, Chen B, et al. A survey of current trends in computational drug repositioning [J]. Briefings in Bioinformatics, 2016, 17(1): 2–12. 链接1

[17] Seifirad S, Haghpanah V. Inappropriate modeling of chronic and complex disorders: How to reconsider the approach in the context of predictive, preventive and personalized medicine, and translational medicine [J]. The EPMA Journal, 2019, 3(10): 195– 209. 链接1

[18] Cunha L, Horvath I, Ferreira S, et al. Preclinical imaging: An essential ally in modern biosciences [J]. Molecular Diagnosis & Therapy, 2014, 18(2): 153–173. 链接1

[19] Gatley S J, Volkow N D, Wang G J, et al. PET imaging in clinical drug abuse research [J]. Current Pharmaceutical Design, 2005, 11(25): 3203–3219. 链接1

[20] 陈凯先. 新药创制: 趋势、挑战和策略思考 [J]. 中国食品药品监 管, 2015 (5): 24–25. Chen K X. Creation of new drugs: Trends, challenges, and strategic thinking [J]. China Food & Drug Administration Magazine, 2015 (5): 24–25.
Chen K X. Creation of new drugs: Trends, challenges, and strategic thinking [J]. China Food & Drug Administration Magazine, 2015 (5): 24–25. Chinese. 链接1

[21] 樊代明. 合理用药和用药合理 [C]//樊代明. 整合医学——理论 与实践. 西安: 世界图书出版公司, 2016: 146–153. Fan D M. The rational use of drugs and reasonable medication [C]// Fan D M. Holistic integrative medicine: Theory & practice. Xi’an: World Publishing Corporation, 2016: 146–153.
Fan D M. The rational use of drugs and reasonable medication [C]// Fan D M. Holistic integrative medicine: Theory & practice. Xi’an: World Publishing Corporation, 2016: 146–153. Chinese.

[22] 杨宝峰. 整合药学之我见 [C]//樊代明. 整合医学——理论与实 践③. 西安: 世界图书出版公司, 2018: 518–522. Yang B F. My opinion on integrative medicine [C]// Fan D M. Holistic integrative medicine: Theory & practice③. Xi’an: World Publishing Corporation, 2018: 518–522.
Yang B F. My opinion on integrative medicine [C]// Fan D M. Holistic integrative medicine: Theory & practice③. Xi’an: World Publishing Corporation, 2018: 518–522. Chinese.

[23] 左晖, 郭晓汐, 张宽仁. 分子靶向药物个体化肿瘤治疗与网络联 合进展 [J]. 中国新药与临床杂志, 2015, 34(5): 330–335. Zuo H, Guo X X, Zhang K R. Individualized application of molecular-targeted drugs against cancer and new development for network medicine therapy [J]. Chinese Journal of New Drugs and Clinical Remedies, 2015, 34(5): 330–335.
Zuo H, Guo X X, Zhang K R. Individualized application of molecular-targeted drugs against cancer and new development for network medicine therapy [J]. Chinese Journal of New Drugs and Clinical Remedies, 2015, 34(5): 330–335. Chinese. 链接1

[24] Vonelstein B, Papadopoulos N, Velculescu V E, et al. Cancer genome landscapes [J]. Science, 2013, 339(6127): 1546–1558. 链接1

[25] 曾浔, 蒋微琴, 尹巍巍, 等. 基于单细胞质谱流式技术的早期肝 癌区域免疫特性的研究 [C]. 上海: 第十三届全国免疫学学术大 会, 2018. Zeng X, Jiang W Q, Yin W W, et al. Study on regional immune characteristics of early hepatocellular carcinoma based on single cell mass spectrometry [C]. Shanghai: The 13th National Academic Congress of Immunology, 2018.
Zeng X, Jiang W Q, Yin W W, et al. Study on regional immune characteristics of early hepatocellular carcinoma based on single cell mass spectrometry [C]. Shanghai: The 13th National Academic Congress of Immunology, 2018. Chinese.

[26] Maher B. Exome sequencing takes center stage in cancer profiling [J]. Nature, 2009, 459(7244): 146–147. 链接1

[27] Angelo M, Bendall S C, Finck R, et al. Multiplexed ion beam imaging of human breast tumors [J]. Nature Medicine, 2014, 20(4): 436–442. 链接1

[28] Harnett J E, Ung C, Hu H, et al. Advancing the pharmacist’s role in promoting the appropriate and safe use of dietary supplements [J]. Complementary Therapies in Medicine, 2019, 44: 174–181. 链接1

相关研究